Therefore, it is reasonable to speculate that BEX1, G6PC and GCLM can be used as potential therapeutic targets of HCC to mediate the mechanism of cuproptosis in hepatocytes. The gene discussed is GCLM; the disease is hepatocellular carcinoma.